Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: Neuroguy who wrote (2508)	4/22/1999 1:37:00 AM
From: B. A. Marlow	Respond to of 10280

Chart tracking performance of selected pharmas/biotechs, SEPR: techstocks.com

To: Neuroguy who wrote (2508)	4/22/1999 11:23:00 AM
From: j_fir2	Read Replies (1) \| Respond to of 10280

"...looking for clues to SEPR." ? Wonder what EB White invested in (besides children)? Will SEPR turn into a super-generic pharma, as Ag suggests? IMHO their egos speak to more than that, though reality will have her way. (I've noticed.) That comparison chart sure is impressive considering SEPR's earnings. I wonder what is in the future. Neurodude, tell me. The thing about antidepressants seems to be that the most popular one is the newest one. I mean, they drive a hard bargain, offering psychic relief in exchange for sexual functioning and/or weight gain. And they are expensive! At least they don't ask for firstborn children. Seems to me Prozac has had an exceptional run for all the reasons we know, but the hope is always for the future, the next one, Celexa, Prozac II?, etc. It just gives me the feeling that, as usual, an investor who has parried all local underwear into SEPR shares in the hopes of being in on the next Microsoft must pay very careful attention, watch the chart, keep up with due dililgence, track down every rumor--dag, I'd better get back to work. Be well. j/fir